Lycium barbarum Glycopeptide Alleviates Neomycin‐Induced Ototoxicity by Inhibiting Tryptophan Hydroxylase‐Mediated Serotonin Biosynthesis
Open Access
- 26 March 2025
- journal article
- Published by Wiley in Advanced Science
- Vol. 12 (29) , e2405850
Abstract
Aminoglycoside antibiotic‐induced sensorineural hearing loss (SNHL) is a common sensory disorder that requires the development of prophylactic and therapeutic interventions. Lycium barbarum glycopeptide (LBGP) is a peptidoglycan isolated and purified from Lycium barbarum polysaccharides that exhibit significant anti‐inflammatory, antioxidant, and neuroprotective effects, but the role of LBGP in aminoglycoside‐induced SNHL has not been well investigated. Here it is shown that LBGP can protect against neomycin‐induced hearing impairment and alleviate oxidative stress in a neomycin‐induced SNHL mouse model. Moreover, it is further found that inhibition of tryptophan hydroxylase (Tph)‐mediated serotonin (5‐HT) biosynthesis plays a key role in the mechanism of action of LBGP in treating neomycin‐induced hearing loss. Systemic delivery of 5‐HT increased neomycin‐induced apoptosis of cochlear hair cells and spiral ganglion neurons, and pharmacological Tph2 inhibition with P‐chlorophenylalanine or Tph2 knock down by AAV‐ie‐ Tph2 effectively attenuated neomycin‐induced hearing dysfunction. Collectively, these results provide a promising strategy for the prevention of SNHL by using natural plant extract which is more available and exhibits lower side effects compared with other otoprotective drugs, and identify Tph2 as a potential pharmacological target for the treatment of aminoglycoside‐induced ototoxicity.Keywords
Funding Information
- National Key Research and Development Program of China (2021YFA1101300)
- National Key Research and Development Program of China (2021YFA1101800)
- National Key Research and Development Program of China (2020YFA0112503)
- National Key Research and Development Program of China (2020YFA0113600)
- National Natural Science Foundation of China (82101228)
- National Natural Science Foundation of China (82030029)
- National Natural Science Foundation of China (81970882)
- National Natural Science Foundation of China (92149304)
- Science and Technology Department of Sichuan Province (2021YFS0371)
- Shenzhen Science and Technology Innovation Program (JCYJ20190814093401920)
- Shenzhen Science and Technology Innovation Program (JCYJ20210324125608022)
This publication has 57 references indexed in Scilit:
- Gut Microbiota‐Derived Indole Derivatives Alleviate Neurodegeneration in Aging through Activating GPR30/AMPK/SIRT1 PathwayMolecular Nutrition & Food Research, 2023
- Inhibiting DNA methylation alleviates cisplatin-induced hearing loss by decreasing oxidative stress-induced mitochondria-dependent apoptosis via the LRP1–PI3K/AKT pathwayActa Pharmaceutica Sinica B, 2021
- Targeting dysregulation of redox homeostasis in noise-induced hearing loss: Oxidative stress and ROS signalingFree Radical Biology and Medicine, 2019
- Distribution of Tryptophan Hydroxylase Immunoreactivity in the Spiral Ganglion Neurons of Mouse CochleaIndian Journal of Otolaryngology and Head & Neck Surgery, 2018
- Gut Microbiota Regulation of Tryptophan Metabolism in Health and DiseaseCell Host & Microbe, 2018
- Effects of Lycium barbarum on the Visual System2017
- Neuro-protective Mechanisms of Lycium barbarumNeuroMolecular Medicine, 2016
- 5-HT6/7 Receptor Antagonists Facilitate Dopamine Release in the Cochlea via a GABAergic Disinhibitory MechanismNeurochemical Research, 2008
- Use of Anti-aging Herbal Medicine, Lycium barbarum, Against Aging-associated Diseases. What Do We Know So Far?Cellular and Molecular Neurobiology, 2007
- A review of approaches to the analysis of 3-nitrotyrosineAmino Acids, 2003